{
  "retracted": false,
  "timestamp": 1420675200000,
  "updates": [
    {
      "timestamp": 1559371394831,
      "identifier": {
        "doi": "10.1007/s11102-014-0628-z"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s11102-014-0585-6"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Erratum to: Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25Â months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III study"
}
